Previous studies from our group have demonstrated that combination treatment with bortezomib and IFN-α synergistically enhances melanoma apoptotic cell death through the Fas Associated Death Domain (FADD)-induced caspase-8 activation [4]. The gene discussed is IFNA2; the disease is melanoma.